George N. Tzanakakis
Irakleion, ESYE43 71003, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.
Journal: Frontiers in medicine
Published: February 19, 2022
Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy.
Journal: Cancers
Published: January 01, 2022
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.
Journal: Cancers
Published: March 30, 2021
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy.
Journal: Biomolecules
Published: January 27, 2021
Assessment of Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles' Biocompatibility with Endothelial Cells in Vitro and Delivery of an Anti-Inflammatory Drug.
Journal: Molecular pharmaceutics
Published: September 28, 2020
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors.
Journal: Cancers
Published: July 15, 2020
Lumican mediates HTB94 chondrosarcoma cell growth via an IGF‑IR/Erk1/2 axis.
Journal: International journal of oncology
Published: March 19, 2020
Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.
Journal: Cells
Published: August 03, 2019
Genotoxic, cytotoxic, and cytopathological effects in rats exposed for 18 months to a mixture of 13 chemicals in doses below NOAEL levels.
Journal: Toxicology letters
Published: June 01, 2019
Last Updated: 09/26/2026